This company listing is no longer active
ALT Stock Overview
Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Analytica Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.001 |
| 52 Week High | AU$0.002 |
| 52 Week Low | AU$0.001 |
| Beta | 1.13 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -50.00% |
| 3 Year Change | -66.67% |
| 5 Year Change | -87.50% |
| Change since IPO | -99.97% |
Recent News & Updates
Shareholder Returns
| ALT | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | -3.0% |
| 1Y | -50.0% | 12.6% | 3.9% |
Return vs Industry: ALT underperformed the Australian Medical Equipment industry which returned 10.1% over the past year.
Return vs Market: ALT underperformed the Australian Market which returned -1.9% over the past year.
Price Volatility
| ALT volatility | |
|---|---|
| ALT Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: ALT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ALT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | n/a | n/a | www.analyticamedical.com |
Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company’s lead product includes PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles.
Analytica Limited Fundamentals Summary
| ALT fundamental statistics | |
|---|---|
| Market cap | AU$4.61m |
| Earnings (TTM) | -AU$2.17m |
| Revenue (TTM) | AU$316.09k |
14.6x
P/S Ratio-2.1x
P/E RatioIs ALT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALT income statement (TTM) | |
|---|---|
| Revenue | AU$316.09k |
| Cost of Revenue | AU$1.15m |
| Gross Profit | -AU$838.90k |
| Other Expenses | AU$1.33m |
| Earnings | -AU$2.17m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00047 |
| Gross Margin | -265.40% |
| Net Profit Margin | -687.14% |
| Debt/Equity Ratio | -116.2% |
How did ALT perform over the long term?
See historical performance and comparison